iBio
IBIO
#9315
Rank
โ‚น7.69 B
Marketcap
โ‚น222.90
Share price
-1.33%
Change (1 day)
-47.25%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): -โ‚น131.39

According to iBio's latest financial reports the company's current EPS (TTM) is -โ‚น141.99. an increase over its 2024 EPS that were of -โ‚น599.31.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025-โ‚น161.35-73.08%
2024-โ‚น599.31-93.88%
2023-โ‚น9,791-8.14%
2022-โ‚น10,65992.67%
2021-โ‚น5,532-80.33%
2020-โ‚น28,122-35.11%
2019-โ‚น43,335-38.96%
2018-โ‚น70,996-6.1%
2017-โ‚น75,60636.67%
2016-โ‚น55,32133.33%
2015-โ‚น41,49150%
2014-โ‚น27,661-53.85%
2013-โ‚น59,931-7.14%
2012-โ‚น64,541-64.1%
2011-โ‚น1,79,79477.27%
2010-โ‚น1,01,422144.44%
2009-โ‚น41,49112.93%
2008-โ‚น36,74112.2%
2007-โ‚น32,746

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,027-823.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
-โ‚น47.95-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚น734.85 417.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น130.00-191.56%๐Ÿ‡บ๐Ÿ‡ธ USA